Rand Paul Review

Rand Paul Review

Share this post

Rand Paul Review
Rand Paul Review
FDA Quickly Moving Towards COVID 2.0
Copy link
Facebook
Email
Notes
More

FDA Quickly Moving Towards COVID 2.0

We stay vigilant and not let Covid tyranny comeback again

Rand Paul Review's avatar
Rand Paul Review
Apr 30, 2025
∙ Paid
198

Share this post

Rand Paul Review
Rand Paul Review
FDA Quickly Moving Towards COVID 2.0
Copy link
Facebook
Email
Notes
More
5
33
Share

Get 50% off for 1 year

If there’s one thing we’ve all learned about big pharma over the years, it’s that under no circumstances can they be trusted. Agencies like the CDC, FDA, and others have consistently sold out the best interests of Americans, all to make a quick buck.

There’s no better example of this than the COVID vaccine mandates we all saw years ago. Everyday folks were pressured, bullied, and outright threatened into receiving these poisonous jabs. Parents heard that their kids would be denied access to schools unless they produced COVID vaccine passports.

All of this happened just for the shots to be ineffective. For all of the government and big pharma’s bullying, they couldn’t even produce a vaccine that lived up to the hype.

The COVID jab never once prevented people from coming down with the virus, nor did it stop the spread. It didn’t take long for Americans to stand up and collectively fight for our right to informed consent.

Nevertheless, this doesn’t mean that big pharma is giving up on its efforts to control Americans and make big money in the process.

If anything, they’re trying to recreate the mayhem they caused with COVID, only this time with the bird flu vaccine.

Do Not Get This Shot Under Any Circumstances

Keep reading with a 7-day free trial

Subscribe to Rand Paul Review to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Rand Paul Review
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More